市場調査レポート

商品コード

アジア太平洋の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

Asia Pacific Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

出版日: 2024年01月03日 | 発行: The Insight Partners

| ページ情報: 英文 167 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,550 556,285円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,550 712,985円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,550 869,685円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

アジア太平洋の分子診断市場は、2022年の34億7,848万米ドルから2030年には96億9,811万米ドルに成長すると予測されています。2022年から2030年までのCAGRは13.7%と推定されます。

分子診断技術の進歩がアジア太平洋の分子診断市場を活性化

分子診断技術およびプラットフォームは、解剖学および臨床病理学のあらゆる分野で利用されています。一塩基多型、欠失、再配列、挿入など、疾患に関連するDNAまたはRNA配列は、分子診断検査で検出することができます。COVID-19の出現後、分子診断法はさらに改良されました。従来、検査にはCTスキャン、血液学的検査、RT-PCRが用いられていました。COVID-19の症例が2020年に急増するにつれ、従来の検査の欠点を克服するため、迅速で精密な検査プラットフォームへのニーズが急増しました。コンピュータ断層撮影法（CT）はコストがかかり、すべての病院で実施できるとは限らないため、無症状の患者のウイルス感染やその他の疾患を検出することができないです。広く用いられているRT-PCR法も、時間と費用がかかり、感染初期の低ウイルス量を検出することができなかった。その結果、研究者たちは、より迅速で費用対効果の高い、SARS-CoV-2を検出する新しいアプローチを開発しました。逆転写ループ媒介等温増幅法（RT-LAMP）、マイクロアレイベースの検出、アプタマーベースの診断、SHERLOCK、SHERLOCKv2、FETバイオセンサー、細胞ベースの電位差診断、分子インプリンティング技術は、COVID-19診断のために開発された新しい分子診断技術の一例です。ここ数年、FDAの報告によると、分子検査、抗原依存性検査、血清学的検査の進歩が承認されています。COVID-19パンデミックを管理し、死亡の程度を軽減するためのさまざまな国の科学界による協力的な取り組みは、分子ツールおよび診断の状況全体に恩恵をもたらしており、これは将来、分子診断市場に大きな機会を創出する可能性が高いです。

アジア太平洋の分子診断市場概要

アジア太平洋には、マレーシア、タイ、インド、シンガポール、フィリピン、ベトナム、インドネシア、中国、日本、オーストラリア、韓国、その他アジア太平洋が含まれます。高齢者人口の増加、がん患者の増加、技術進歩の拡大、新興企業、バイオテクノロジー企業、バイオ製薬企業の増加がこの地域の分子診断市場を牽引しています。さらに、同地域における研究活動の活発化、がん治療の質を高める団体や組織の存在が、分子診断市場の成長に寄与しています。

アジア太平洋の分子診断市場の収益と2030年までの予測（百万米国ドル）

アジア太平洋の分子診断市場セグメンテーション

アジア太平洋の分子診断市場は、疾患領域、技術、製品・サービス、エンドユーザー、国に区分されます。

疾患領域別に見ると、アジア太平洋の分子診断市場は感染症、腫瘍、遺伝子検査、心疾患、免疫系疾患、その他に区分されます。感染症分野は2022年にアジア太平洋の分子診断市場で最大のシェアを記録しました。

技術別では、アジア太平洋の分子診断市場は、ポリメラーゼ連鎖反応（PCR）、in situハイブリダイゼーション、等温核酸増幅技術（INAAT）、DNAシーケンシングおよび次世代シーケンシング（NGS）、DNAマイクロアレイ、その他に区分されます。ポリメラーゼ連鎖反応（PCR）セグメントは、2022年にアジア太平洋の分子診断市場で最大のシェアを記録しました。ポリメラーゼ連鎖反応（PCR）はさらにRT-PCR、qPCR、マルチプレックスPCR、その他に細分化されます。

製品とサービスに基づき、アジア太平洋の分子診断市場はアッセイとキット、機器、サービスとソフトウェアに区分されます。2022年のアジア太平洋の分子診断市場シェアは、アッセイとキット分野が最大でした。

エンドユーザー別では、アジア太平洋の分子診断市場は診断ラボ、病院・クリニック、研究・学術機関、その他に区分されます。2022年のアジア太平洋の分子診断市場シェアは、診断ラボ部門が最大でした。

国別に見ると、アジア太平洋の分子診断市場は、インド、シンガポール、マレーシア、フィリピン、タイ、インドネシア、ベトナム、中国、日本、オーストラリア、韓国、その他アジア太平洋に分類されます。2022年のアジア太平洋の分子診断市場は中国が支配的でした。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG、Novartis AG、TBG Diagnostics Limitedは、アジア太平洋の分子診断市場で事業を展開している大手企業です。

List Of Tables

Table 1. Asia Pacific Molecular Diagnostics Market Segmentation
Table 2. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 3. China:Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 4. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 5. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 6. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 7. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
Table 8. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
Table 9. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 10. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
Table 11. Japan: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 12. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 13. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 14. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 15. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 16. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 17. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 18. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 19. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 20. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 21. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 22. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 23. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 24. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 25. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 26. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 27. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 28. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 29. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 30. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 31. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
Table 32. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 33. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 34. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 35. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 36. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 37. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 38. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 39. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 40. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 43. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 44. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 45. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 46. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 47. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 48. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 49. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 50. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 51. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 52. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 53. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 54. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 55. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 56. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 57. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 58. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 59. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 60. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 61. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 62. Organic Developments Done By Companies
Table 63. Inorganic Developments Done By Companies
Table 64. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

Figure 1. Asia Pacific - PEST Analysis
Figure 2. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Asia Pacific Molecular Diagnostics Market, By Country, 2022 (US$ Mn)
Figure 33. Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 39. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 40. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 43. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 45. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. Growth Strategies Done by the Companies in the Market (%)

Product Code: TIPRE00026008

The Asia Pacific molecular diagnostics market is expected to grow from US$ 3,478.48 million in 2022 to US$ 9,698.11 million by 2030. It is estimated to grow at a CAGR of 13.7% from 2022 to 2030.

Advancements in Molecular Diagnostics Technologies Fuels Asia Pacific Molecular Diagnostics Market

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

Asia Pacific Molecular Diagnostics Market Overview

Asia Pacific includes Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing cancer cases, growing technological advancements, and increasing number of startups, biotechnology, and biopharmaceutical companies are driving the molecular diagnostics market in this region. Moreover, the rise in research activities in the region and the presence of associations or organizations enhancing the quality of care in cancer contribute to the molecular diagnostics market growth.

Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Molecular Diagnostics Market Segmentation

The Asia Pacific molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Asia Pacific molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on technology, the Asia Pacific molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Asia Pacific molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Asia Pacific molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on end users, the Asia Pacific molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Asia Pacific molecular diagnostics market share in 2022.

Based on country, the Asia Pacific molecular diagnostics market has been categorized into India, Singapore, Malaysia, Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the Asia Pacific molecular diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Molecular Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
- 5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
- 5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
- 5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
- 5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:

6. Molecular Diagnostics Market - Asia Pacific Market Analysis

6.1 Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

7.1 Overview
7.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
- 7.4.1 Overview
- 7.4.2 Infectious Disease: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
- 7.5.1 Overview
- 7.5.2 Genetic Testing: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
- 7.6.1 Overview
- 7.6.2 Cardiac Diseases: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
- 7.7.1 Overview
- 7.7.2 Immune System Disorders: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
- 8.3.1 Overview
- 8.3.2 PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 RT-PCR
    - 8.3.2.1.1 Overview
- 8.3.3 RT-PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.3.1 qPCR
    - 8.3.3.1.1 Overview
- 8.3.4 PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.4.1 Multiplex PCR
    - 8.3.4.1.1 Overview
- 8.3.5 Multiplex PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.5.1 Others
    - 8.3.5.1.1 Overview
- 8.3.6 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Overview
- 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
- 8.5.1 Overview
- 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
- 8.6.1 Overview
- 8.6.2 DNA Microarrays: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
- 8.7.1 Overview
- 8.7.2 In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

9.1 Overview
9.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
- 9.3.1 Overview
- 9.3.2 Assays and Kits: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
- 9.4.1 Overview
- 9.4.2 Instruments: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
- 9.5.1 Overview
- 9.5.2 Services and Software: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostics Laboratories: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Molecular Diagnostics Market - Country Analysis

11.1 Asia Pacific Molecular Diagnostics Market, Revenue and Forecast to 2030
- 11.1.1 Overview
  - 11.1.1.1 Asia Pacific Molecular Diagnostics Market by Country
- 11.1.2 China
  - 11.1.2.1 Overview
- 11.1.3 China: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.4 China: Molecular Diagnostics Market, by Disease Area
- 11.1.5 China: Molecular Diagnostics Market, by Technology
  - 11.1.5.1 China: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.6 China:Molecular Diagnostics Market, by Product and Services
- 11.1.7 China: Molecular Diagnostics Market, by End User
- 11.1.8 Japan
  - 11.1.8.1 Overview
- 11.1.9 Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.10 Japan: Molecular Diagnostics Market, by Disease Area
- 11.1.11 Japan: Molecular Diagnostics Market, by Technology
  - 11.1.11.1 Japan: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.12 Japan: Molecular Diagnostics Market, by Product and Services
- 11.1.13 Japan: Molecular Diagnostics Market, by End User
- 11.1.14 India
  - 11.1.14.1 Overview
- 11.1.15 India: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.16 India: Molecular Diagnostics Market, by Disease Area
- 11.1.17 India: Molecular Diagnostics Market, by Technology
  - 11.1.17.1 India: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.18 India: Molecular Diagnostics Market, by Product and Services
- 11.1.19 India: Molecular Diagnostics Market, by End User
- 11.1.20 Australia
  - 11.1.20.1 Overview
- 11.1.21 Australia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.22 Australia: Molecular Diagnostics Market, by Disease Area
- 11.1.23 Australia: Molecular Diagnostics Market, by Technology
  - 11.1.23.1 Australia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.24 Australia: Molecular Diagnostics Market, by Product and Services
- 11.1.25 Australia: Molecular Diagnostics Market, by End User
- 11.1.26 South Korea
  - 11.1.26.1 Overview
- 11.1.27 South Korea: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.28 South Korea: Molecular Diagnostics Market, by Disease Area
- 11.1.29 South Korea: Molecular Diagnostics Market, by Technology
  - 11.1.29.1 South Korea: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.30 South Korea: Molecular Diagnostics Market, by Product and Services
- 11.1.31 South Korea: Molecular Diagnostics Market, by End User
- 11.1.32 Singapore
  - 11.1.32.1 Overview
- 11.1.33 Singapore: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.34 Singapore: Molecular Diagnostics Market, by Disease Area
- 11.1.35 Singapore: Molecular Diagnostics Market, by Technology
  - 11.1.35.1 Singapore: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.36 Singapore: Molecular Diagnostics Market, by Product and Services
- 11.1.37 Singapore: Molecular Diagnostics Market, by End User
- 11.1.38 Malaysia
  - 11.1.38.1 Overview
- 11.1.39 Malaysia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.40 Malaysia: Molecular Diagnostics Market, by Disease Area
- 11.1.41 Malaysia: Molecular Diagnostics Market, by Technology
  - 11.1.41.1 Malaysia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.42 Malaysia: Molecular Diagnostics Market, by Product and Services
- 11.1.43 Malaysia: Molecular Diagnostics Market, by End User
- 11.1.44 Philippines
  - 11.1.44.1 Overview
- 11.1.45 Philippines: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.46 Philippines: Molecular Diagnostics Market, by Disease Area
- 11.1.47 Philippines: Molecular Diagnostics Market, by Technology
  - 11.1.47.1 Philippines: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.48 Philippines: Molecular Diagnostics Market, by Product and Services
- 11.1.49 Philippines: Molecular Diagnostics Market, by End User
- 11.1.50 Thailand
  - 11.1.50.1 Overview
- 11.1.51 Thailand: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.52 Thailand: Molecular Diagnostics Market, by Disease Area
- 11.1.53 Thailand: Molecular Diagnostics Market, by Technology
  - 11.1.53.1 Thailand: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.54 Thailand: Molecular Diagnostics Market, by Product and Services
- 11.1.55 Thailand: Molecular Diagnostics Market, by End User
- 11.1.56 Indonesia
  - 11.1.56.1 Overview
- 11.1.57 Indonesia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.58 Indonesia: Molecular Diagnostics Market, by Disease Area
- 11.1.59 Indonesia: Molecular Diagnostics Market, by Technology
  - 11.1.59.1 Indonesia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.60 Indonesia: Molecular Diagnostics Market, by Product and Services
- 11.1.61 Indonesia: Molecular Diagnostics Market, by End User
- 11.1.62 Vietnam
  - 11.1.62.1 Overview
- 11.1.63 Vietnam: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.64 Vietnam: Molecular Diagnostics Market, by Disease Area
- 11.1.65 Vietnam: Molecular Diagnostics Market, by Technology
  - 11.1.65.1 Vietnam: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.66 Vietnam: Molecular Diagnostics Market, by Product and Services
- 11.1.67 Vietnam: Molecular Diagnostics Market, by End User
- 11.1.68 Rest of Asia Pacific
  - 11.1.68.1 Overview
- 11.1.69 Rest of Asia Pacific: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.70 Rest of Asia Pacific: Molecular Diagnostics Market, by Disease Area
- 11.1.71 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology
  - 11.1.71.1 Rest of Asia Pacific: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.72 Rest of Asia Pacific: Molecular Diagnostics Market, by Product and Services
- 11.1.73 Rest of Asia Pacific: Molecular Diagnostics Market, by End User

12. Asia Pacific Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Asia Pacific Molecular Diagnostics Market, Key Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Agilent Technologies Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Qiagen NV
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 bioMerieux SA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Illumina Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Danaher
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens Healthineers AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Novartis AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 TBG Diagnostics Limited
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

アジア太平洋の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

Asia Pacific Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章アジア太平洋の分子診断市場情勢

第5章アジア太平洋の分子診断市場力学：主要産業力学

第6章分子診断市場-アジア太平洋市場分析

第7章アジア太平洋の分子診断市場：収益と2030年までの予測 - 疾患領域別

第8章アジア太平洋の分子診断市場：収益と2030年までの予測 - 技術別

第9章アジア太平洋の分子診断市場：収益と2030年までの予測 - 製品・サービス別

第10章アジア太平洋の分子診断市場：収益と2030年までの予測 - エンドユーザー別

第11章アジア太平洋の分子診断市場：国別分析

第12章アジア太平洋の分子診断市場業界情勢

第13章アジア太平洋の分子診断市場、主要企業プロファイル

第14章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Asia Pacific Molecular Diagnostics Market Landscape

5. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics

6. Molecular Diagnostics Market - Asia Pacific Market Analysis

7. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

8. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

9. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

10. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

11. Asia Pacific Molecular Diagnostics Market - Country Analysis

12. Asia Pacific Molecular Diagnostics Market Industry Landscape

13. Asia Pacific Molecular Diagnostics Market, Key Company Profiles

14. Appendix

アジア太平洋の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

Asia Pacific Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 アジア太平洋の分子診断市場情勢

第5章 アジア太平洋の分子診断市場力学：主要産業力学

第6章 分子診断市場-アジア太平洋市場分析

第7章 アジア太平洋の分子診断市場：収益と2030年までの予測 - 疾患領域別

第8章 アジア太平洋の分子診断市場：収益と2030年までの予測 - 技術別

第9章 アジア太平洋の分子診断市場：収益と2030年までの予測 - 製品・サービス別

第10章 アジア太平洋の分子診断市場：収益と2030年までの予測 - エンドユーザー別

第11章 アジア太平洋の分子診断市場：国別分析

第12章 アジア太平洋の分子診断市場業界情勢

第13章 アジア太平洋の分子診断市場、主要企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Asia Pacific Molecular Diagnostics Market Landscape

5. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics

6. Molecular Diagnostics Market - Asia Pacific Market Analysis

7. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

8. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

9. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

10. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

11. Asia Pacific Molecular Diagnostics Market - Country Analysis

12. Asia Pacific Molecular Diagnostics Market Industry Landscape

13. Asia Pacific Molecular Diagnostics Market, Key Company Profiles

14. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章アジア太平洋の分子診断市場情勢

第5章アジア太平洋の分子診断市場力学：主要産業力学

第6章分子診断市場-アジア太平洋市場分析

第7章アジア太平洋の分子診断市場：収益と2030年までの予測 - 疾患領域別

第8章アジア太平洋の分子診断市場：収益と2030年までの予測 - 技術別

第9章アジア太平洋の分子診断市場：収益と2030年までの予測 - 製品・サービス別

第10章アジア太平洋の分子診断市場：収益と2030年までの予測 - エンドユーザー別

第11章アジア太平洋の分子診断市場：国別分析

第12章アジア太平洋の分子診断市場業界情勢

第13章アジア太平洋の分子診断市場、主要企業プロファイル

第14章付録